Becton Dickinson & Co is a medical company located in New Jersey, United States, which is part of the Healthcare sector, and is traded under the ticker BDX on the NYSE exchange.
Becton Dickinson & Co stock last closed at $154.13, down 1.53% from the previous day, and has decreased 33.52% in one year. It has underperformed other stocks in the Medical Instruments & Supplies industry by 0.2 percentage points. Becton Dickinson & Co stock is currently +0.24% from its 52-week low of $153.76, and -33.51% from its 52-week high of $231.82.
There are currently 284.74M shares of BDX outstanding. The market cap of BDX is $43.89B. In the last 24 hours, 3.72M BDX shares were traded.
You need a brokerage account to access the NYSE market and buy BDX shares.
We believe that eToro is the best place to buy stocks. eToro gives you:
Get $10 towards your purchase of stock by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've selected the best brokerage, you'll need to fill out some personal details so you are able to buy BDX today.
Now that you've filled out your info on the best stock market app, your next step is to transfer the money for your investment:
Check out the tutorial below for more details depositing money into your new investment account.
Once you have figured out the best place to buy Becton Dickinson & Co stock, it's crucial to evaluate their stock prior to buying, so you truly wrap your head around the risk as well as the opportunity.
WallStreetZen was created to help part-time investors perform better fundamental analysis.
You can view all of the due diligence checks on BDX's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge BDX's true value.
Using relative valuations metrics:
You can access more valuation research on BDX's stock here.
Out of 10 Wall Street analysts who research BDX, the consensus analyst rating on BDX is a Buy
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
Jason Bednar, a bottom 3% analyst from Piper Sandler reiterates BDX with a hold rating and lowers their BDX price target from $205.00 to $170.00, on Feb 10, 2026.
Lawrence Biegelsen, a bottom 7% analyst from Wells Fargo maintains BDX with a hold rating and lowers their BDX price target from $184.00 to $157.00, on Feb 10, 2026.
Rick Wise, a top 13% analyst from Stifel Nicolaus maintains BDX with a strong buy rating and raises their BDX price target from $210.00 to $215.00, on Jan 7, 2026.
Stifel Nicolaus's Rick Wise raised their price target on Becton Dickinson & Co (NYSE: BDX) by 2.4% from $210 to $215 on 2026/01/07. The analyst maintained their Strong Buy rating on the stock.
Hiking their price target on Becton Dickinson & Co. in a 2026 preview note on names in their Large-cap MedTech portfolio, Wise posited that the setup for this year is constructive for the group after 2025 pressures.
The analyst named Boston Scientific, Edwards Lifesciences, and Solventum as Stifel Nicolaus' top sector ideas entering the year.
Travis Steed, a top 40% analyst from Bank of America maintains BDX with a hold rating and raises their BDX price target from $190.00 to $207.00, on Jan 5, 2026.
Patrick Wood, a top 29% analyst from Morgan Stanley maintains BDX with a strong buy rating and raises their BDX price target from $197.00 to $210.00, on Dec 2, 2025.
You can dive deeper into what analysts are saying on the Becton Dickinson & Co stock forecast page.
Last year, BDX earnings were $1.76B. During the past 5 year, BDX's earnings have grown by 3.23% per year. This was slower than the Medical Instruments & Supplies industry average of 10.69%.
Last year, BDX revenue was $21.92B. During the past five year, BDX's revenue has grown by 5.02% per year. This was slower than the Medical Instruments & Supplies industry average of 18.63%.
Find out more about BDX's earnings and revenue performance here.
Over the past 12 months, insiders at BDX have sold more shares than they have bought.
Michael Feld, EVP Chief Revenue Officer of BDX, was the latest BDX insider to sell. They sold $13,638.00 worth of BDX shares on Feb 26, 2026.
Get more info about who owns BDX stock here.
Becton Dickinson & Co pays a dividend of 2.71%, compared to the Medical Instruments & Supplies industry's average dividend yield of 2.45%. If you owned $1,000 worth of BDX stock, you would have received $27.12 in the past year.
Becton Dickinson & Co dividend payments have consistently grown over the past decade and have remained stable.
Find more data about Becton Dickinson & Co dividend yield and history here.
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
There are two primary order types:
Hit the Open Trade button and your broker will place your order.
If you want additional help investing in stocks on eToro, click the helpful video below:
Now that you own some shares in BDX, you'll want to stay up-to-date on your new investment.
Add BDX to a watchlist to track your BDX stock.
To summarize, here are the 6 steps to buy Becton Dickinson & Co stock:
If you need a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you want to keep an eye on your new investment in Becton Dickinson & Co, add BDX to your watchlist by clicking the button below.